Contact
Please use this form to send email to PR contact of this press release:
Flexion Therapeutics Announces Treatment of First Patient in Second Cohort of FX201 Phase 1 Dose-Escalation Trial
TO:
Please use this form to send email to PR contact of this press release:
Flexion Therapeutics Announces Treatment of First Patient in Second Cohort of FX201 Phase 1 Dose-Escalation Trial
TO: